Lv1
30 积分 2024-10-12 加入
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC
1天前
求助中
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma
1天前
已完结
A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression
14天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
14天前
已完结
Engineering cytokine therapeutics
19天前
已完结
Harnessing cytokines and chemokines for cancer therapy
20天前
已完结
T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy
22天前
已完结
Clinical and translational attributes of immune-related adverse events
28天前
已完结
Immune-related adverse events of checkpoint inhibitors
28天前
已完结
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies
28天前
已完结
皖公网安备34019202002308
